SOURCE: BioPharmetics, Inc.

March 16, 2006 10:31 ET

BioPharmetics, Inc. Launches Online Store to Meet Consumer Demands for Products

NORTH HOLLYWOOD, CA -- (MARKET WIRE) -- March 16, 2006 -- BioPharmetics, Inc. (OTC: BCSM) formerly known as BTG Cosmetics, announced the formal launch of their online store to meet the increasing demand from consumers for their products. The site can be accessed at

"After our thorough Beta testing of the site, we're pleased to make this announcement that the BioPharmetics online store is up and ready for business. Since we launched the Molo Africa™, Micha™, and Isseo™ Men's Skin care products into the marketplace, our phones have been ringing off the hook from consumers seeking to purchase these incredible products," states Mr. Paul D. Lisenby, CEO of BioPharmetics, Inc. "Now that our store is up and running, consumers can now order online and we can process and ship the orders very quickly. Over the coming weeks, we'll be adding over 100 more products to our store. This direct-to-consumer sale allows the company to meet our consumer demands and also increases our profit margin tremendously."

About BioPharmetics, Inc. (OTC: BCSM)

BioPharmetics, Inc., formerly known as BTG Cosmetics, Inc., is a manufacturer and distributor of quality pharmaceutical, cosmetic, and anti-aging products. The company has three divisions: biotechnology, pharmaceuticals, and cosmetics/cosmeceuticals, working in unison to develop, manufacture, and distribute, high-quality products in the retail, wholesale, and professional markets. Brands currently offered include Toma™, Isseo™, Molo Africa™, Micha™, and Natural Angel™. BioPharmetics, Inc. also private labels many brands of cosmetics and Cosmeceuticals for salons and retail stores as well as compounding specialized prescriptions for doctors nationwide.

For information on BioPharmetics, Inc. visit their website at

Safe Harbor

This press release contains or may contain forward-looking statements such as statements regarding the Company's growth and profitability, growth strategy, liquidity and access to public markets, operating expense reduction, and trends in the industry in which the Company operates. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in the Company's filings with the Securities and Exchange Commission. The Company assumes no obligation to update these forward-looking statements to reflect actual results, changes in risks, uncertainties or assumptions underlying or affecting such statements, or for prospective events that may have a retroactive effect.

Contact Information

  • Contact:
    Paul D. Lisenby
    BioPharmetics, Inc.